Advertisement
Canada markets open in 1 hour 54 minutes
  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CAD/USD

    0.7294
    -0.0007 (-0.09%)
     
  • CRUDE OIL

    81.51
    -0.39 (-0.48%)
     
  • Bitcoin CAD

    90,594.38
    +224.70 (+0.25%)
     
  • CMC Crypto 200

    1,422.01
    +7.25 (+0.51%)
     
  • GOLD FUTURES

    2,316.50
    -29.90 (-1.27%)
     
  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • NASDAQ futures

    17,409.25
    +59.25 (+0.34%)
     
  • VOLATILITY

    16.62
    -0.32 (-1.89%)
     
  • FTSE

    8,057.26
    +33.39 (+0.42%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6834
    -0.0016 (-0.23%)
     

What to Expect from Johnson & Johnson and Gilead Sciences’ EPS

What to Expect from Johnson & Johnson and Gilead Sciences’ EPS

In its first-quarter earnings press release, Johnson & Johnson (JNJ) has increased its fiscal 2019 adjusted diluted operational EPS guidance from the previously projected $8.65 to $8.80, which implies YoY growth of 5.7%–7.6%, to $8.73–$8.83, which implies a YoY rise of 6.7%–7.9%. The company also increased the lower end and narrowed its fiscal 2019 adjusted diluted EPS guidance from $8.50–$8.65.